Clin2
NCT06902974Possibly a fitRecruiting

Psilocybin therapy for PTSD from sexual assault

Post Traumatic Stress DisorderPTSD

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
70 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a woman (cisgender) aged 18 or older.
  • Your main trauma is a sexual assault that happened at least 6 months ago, and you still have PTSD symptoms from it.
  • You can swallow pills and agree to be driven home after the dosing session.
  • You agree to avoid alcohol, caffeine, and nicotine around dosing times, and not start new medications or therapy during the study.
  • If you can get pregnant, you must use effective birth control and have negative pregnancy tests.
  • You don't have certain mental health conditions like schizophrenia or bipolar I, or a recent stroke or heart problem.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas
NCT06386003Recruiting· Phase 2
Psilocybin and talk therapy for chronic PTSD

This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.

Toronto, Ontario
NCT07104916Recruiting· Phase 2
Mindfulness and psilocybin therapy for PTSD

This study tests whether a combination of mindfulness training and a single dose of psilocybin can help reduce PTSD symptoms. It is for people with moderate-to-severe PTSD who are not on certain medications and do not have major health problems.

Columbus, Ohio
NCT07332143Not yet recruiting· Phase 2
Psilocybin therapy for PTSD in Georgia veterans

This trial tests whether a drug called psilocybin, combined with therapy, can help treat PTSD. It is for Georgia military members and veterans who have had PTSD for at least 6 months.

Atlanta, Georgia
NCT07745569Not yet recruiting· Phase 2
Psychedelic therapy study for depression or PTSD

This study tests whether electromagnetic brain stimulation and a psychedelic drug called psilocybin can help people with depression or PTSD. It aims to see how these treatments affect mood and behavior, and whether they are safe and helpful.

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.